Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Gains from Investment Securities (2023 - 2026)

Verastem (VSTM) posted quarterly Gains from Investment Securities of -$9.3 million for Q1 2026, down 485.89% year-over-year from $2.4 million in Q1 2025, and up 11.08% quarter-over-quarter from -$10.5 million in Q4 2025.

Analysis

Verastem (VSTM) Gains from Investment Securities (2023 - 2026) Analysis & Trends

Verastem's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$9.3 million for Q1 2026.

  • In Q1 2026, Gains from Investment Securities fell 485.89% year-over-year to -$9.3 million; the TTM figure through Mar 2026 stood at $15.8 million (down 72.37% YoY), while the FY2025 annual figure was $27.5 million, up 43.57% from the prior year.
  • Gains from Investment Securities for Q1 2026 stood at -$9.3 million, up from -$10.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $55.9 million in Q3 2025, with the low at -$20.3 million in Q2 2025.
  • The 4-year median for Gains from Investment Securities is $5.5 million (2023), against an average of $9.1 million.
  • The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities soared 313.93% in 2025, then slumped 485.89% in 2026.
  • Verastem's Gains from Investment Securities stood at $8.5 million in 2023, then soared by 284.08% to $32.6 million in 2024, then sank by 132.16% to -$10.5 million in 2025, then grew by 11.08% to -$9.3 million in 2026.
  • Business Quant data shows VSTM's Gains from Investment Securities at -$9.3 million in Q1 2026, -$10.5 million in Q4 2025, and $55.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.32 Mn
Dec 31, 2025 -10.49 Mn
Sep 30, 2025 55.88 Mn
Jun 30, 2025 -20.32 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 32.61 Mn
Sep 30, 2024 13.50 Mn
Jun 30, 2023 8.49 Mn